skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 41,757  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Human γδ T lymphocytes induce robust NK cell–mediated antitumor cytotoxicity through CD137 engagement
Material Type:
Article
Add to My Research

Human γδ T lymphocytes induce robust NK cell–mediated antitumor cytotoxicity through CD137 engagement

Blood, 2010-09, Vol.116 (10), p.1726-1733 [Peer Reviewed Journal]

2010 American Society of Hematology ;2010 by The American Society of Hematology 2010 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2009-07-234211 ;PMID: 20519625

Full text available

2
CD27 is required for protective lytic EBV antigen–specific CD8+ T-cell expansion
Material Type:
Article
Add to My Research

CD27 is required for protective lytic EBV antigen–specific CD8+ T-cell expansion

Blood, 2021-06, Vol.137 (23), p.3225-3236 [Peer Reviewed Journal]

2021 American Society of Hematology ;Copyright © 2021 American Society of Hematology. ;2021 by The American Society of Hematology 2021 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020009482 ;PMID: 33827115

Full text available

3
IMMU-26. HEIGHTENED LEVELS OF CIRCULATING CELL-FREE DNA CONTRIBUTE TO PERIPHERAL IMMUNOSUPPRESSION DURING GBM PROGRESSION
Material Type:
Article
Add to My Research

IMMU-26. HEIGHTENED LEVELS OF CIRCULATING CELL-FREE DNA CONTRIBUTE TO PERIPHERAL IMMUNOSUPPRESSION DURING GBM PROGRESSION

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii136-vii137 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.523

Full text available

4
IMMU-13. PROMOTER DEMETHYLATION OF NY-ESO-1 PRIMES GLIOBLASTOMA FOR IMMUNOTHERAPEUTIC TARGETING
Material Type:
Article
Add to My Research

IMMU-13. PROMOTER DEMETHYLATION OF NY-ESO-1 PRIMES GLIOBLASTOMA FOR IMMUNOTHERAPEUTIC TARGETING

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii133-vii134 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.511

Full text available

5
IMMU-14. MENINGEAL PLASMA CELLS MOUNT AN IMMUNOLOGICAL DEFENSE AGAINST GLIOBLASTOMA
Material Type:
Article
Add to My Research

IMMU-14. MENINGEAL PLASMA CELLS MOUNT AN IMMUNOLOGICAL DEFENSE AGAINST GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii134-vii134 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.512

Full text available

6
IMMU-17. LEVERAGING CORE EPIGENETIC PROGRAMMING OF IMMUNOSUPPRESSIVE MYELOID CELLS FOR THERAPEUTIC TARGETING OF GLIOBLASTOMA
Material Type:
Article
Add to My Research

IMMU-17. LEVERAGING CORE EPIGENETIC PROGRAMMING OF IMMUNOSUPPRESSIVE MYELOID CELLS FOR THERAPEUTIC TARGETING OF GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii134-vii135 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.515

Full text available

7
IMMU-22. REPROGRAMMING OF MICROGLIA/MACROPHAGES IN GLIOBLASTOMA IMPROVES ANTI-TUMOR T CELL RESPONSES
Material Type:
Article
Add to My Research

IMMU-22. REPROGRAMMING OF MICROGLIA/MACROPHAGES IN GLIOBLASTOMA IMPROVES ANTI-TUMOR T CELL RESPONSES

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii136-vii136 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.520

Full text available

8
IMMU-41. VERSATILE MRNA-NANOPARTICLE PLATFORM TO REPROGRAM THE BRAIN TUMOR MICROENVIRONMENT AND PREDICT TREATMENT OUTCOME
Material Type:
Article
Add to My Research

IMMU-41. VERSATILE MRNA-NANOPARTICLE PLATFORM TO REPROGRAM THE BRAIN TUMOR MICROENVIRONMENT AND PREDICT TREATMENT OUTCOME

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii140-vii140 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.538

Full text available

9
IMMU-08. RAGE ABLATION ATTENUATES GLIOMA PROGRESSION AND ENHANCES TUMOR IMMUNE RESPONSES BY SUPPRESSING GALECTIN-3 EXPRESSION
Material Type:
Article
Add to My Research

IMMU-08. RAGE ABLATION ATTENUATES GLIOMA PROGRESSION AND ENHANCES TUMOR IMMUNE RESPONSES BY SUPPRESSING GALECTIN-3 EXPRESSION

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii132-vii133 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.506

Full text available

10
IMMU-20. MODULATION OF THE PERIPHERAL T CELL BIOLOGY IN GLIOBLASTOMA
Material Type:
Article
Add to My Research

IMMU-20. MODULATION OF THE PERIPHERAL T CELL BIOLOGY IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii135-vii135 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.518

Full text available

11
IMMU-05. THE INFLUENCE OF THE KETOGENIC DIET ON THE IMMUNE TOLERANT MICROENVIRONMENT IN GLIOBLASTOMA
Material Type:
Article
Add to My Research

IMMU-05. THE INFLUENCE OF THE KETOGENIC DIET ON THE IMMUNE TOLERANT MICROENVIRONMENT IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii132-vii132 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.503

Full text available

12
IMMU-43. CXCR3 SIGNALING ENGAGES GLIOMA INFILTRATING T CELLS AND IS REQUIRED FOR THE ANTITUMOR EFFICACY OF INNATE STIMULATING IMMUNOTHERAPY
Material Type:
Article
Add to My Research

IMMU-43. CXCR3 SIGNALING ENGAGES GLIOMA INFILTRATING T CELLS AND IS REQUIRED FOR THE ANTITUMOR EFFICACY OF INNATE STIMULATING IMMUNOTHERAPY

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii140-vii141 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.540

Full text available

13
IMMU-16. SOMATIC MUTATIONS IN HUMAN LEUKOCYTE ANTIGEN GENES AND ANTIGEN PRESENTATION PATHWAY GENES IN MALIGNANT GLIOMA
Material Type:
Article
Add to My Research

IMMU-16. SOMATIC MUTATIONS IN HUMAN LEUKOCYTE ANTIGEN GENES AND ANTIGEN PRESENTATION PATHWAY GENES IN MALIGNANT GLIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii134-vii134 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.514

Full text available

14
IMMU-15. HUMAN ALLOGENIC γδ T CELLS KILL PATIENT-DERIVED GLIOBLASTOMA CELLS IN A PVR- AND DNAM-1-DEPENDENT MANNER
Material Type:
Article
Add to My Research

IMMU-15. HUMAN ALLOGENIC γδ T CELLS KILL PATIENT-DERIVED GLIOBLASTOMA CELLS IN A PVR- AND DNAM-1-DEPENDENT MANNER

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii134-vii134 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.513

Full text available

15
IMMU-23. ELIMINATING MONOCYTE CHEMOATTRACTION INVOKES COMPENSATORY NEUTROPHIL INFLUX AND PRONEURAL TO MESENCHYMAL TRANSITION IN GLIOBLASTOMA
Material Type:
Article
Add to My Research

IMMU-23. ELIMINATING MONOCYTE CHEMOATTRACTION INVOKES COMPENSATORY NEUTROPHIL INFLUX AND PRONEURAL TO MESENCHYMAL TRANSITION IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii136-vii136 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.521

Full text available

16
IMMU-09. IMMUNOLOGICAL CHARACTERIZATION OF PEDIATRIC BRAIN TUMORS HAS CLINICAL IMPLICATIONS FOR PATIENT MANAGEMENT AND PROGNOSIS
Material Type:
Article
Add to My Research

IMMU-09. IMMUNOLOGICAL CHARACTERIZATION OF PEDIATRIC BRAIN TUMORS HAS CLINICAL IMPLICATIONS FOR PATIENT MANAGEMENT AND PROGNOSIS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii133-vii133 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.507

Full text available

17
IMMU-42. ADOPTIVE HEMATOPOIETIC STEM CELL AND APD1 THERAPY CONVERGE IN THE THYMUS TO PROMOTE ANTI-GLIOBLASTOMA IMMUNITY
Material Type:
Article
Add to My Research

IMMU-42. ADOPTIVE HEMATOPOIETIC STEM CELL AND APD1 THERAPY CONVERGE IN THE THYMUS TO PROMOTE ANTI-GLIOBLASTOMA IMMUNITY

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii140-vii140 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.539

Full text available

18
IMMU-10. EXPLORING THE IMMUNOLOGIC CONSEQUENCES OF ATRX DEFICIENCY IN GLIOMA
Material Type:
Article
Add to My Research

IMMU-10. EXPLORING THE IMMUNOLOGIC CONSEQUENCES OF ATRX DEFICIENCY IN GLIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii133-vii133 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.508

Full text available

19
IMMU-40. KINETICS OF DEXAMETHASONE-INDUCED ALTERATIONS OF DIVERSE IMMUNE SUBSETS IN VIVO
Material Type:
Article
Add to My Research

IMMU-40. KINETICS OF DEXAMETHASONE-INDUCED ALTERATIONS OF DIVERSE IMMUNE SUBSETS IN VIVO

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii140-vii140 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.537

Full text available

20
IMMU-11. NONO IS A NEW ADENOVIRUS SENSOR: IMPLICATION FOR VIROTHERAPY
Material Type:
Article
Add to My Research

IMMU-11. NONO IS A NEW ADENOVIRUS SENSOR: IMPLICATION FOR VIROTHERAPY

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii133-vii133 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.509

Full text available

Results 1 - 20 of 41,757  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (38,352)

Refine My Results

Creation Date 

From To
  1. Before 1977  (44)
  2. 1977 To 1988  (12,954)
  3. 1989 To 2000  (22,719)
  4. 2001 To 2013  (4,920)
  5. After 2013  (1,174)
  6. More options open sub menu

Language 

  1. English  (41,753)
  2. Japanese  (5,112)
  3. French  (14)
  4. German  (10)
  5. Norwegian  (5)
  6. Russian  (3)
  7. Portuguese  (3)
  8. Latin  (2)
  9. Spanish  (2)
  10. Swedish  (1)
  11. More options open sub menu

Searching Remote Databases, Please Wait